- Home
- CEE vs ANIX Comparison
CEE vs ANIX Comparison
Compare CEE & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CEE | ANIX |
|---|---|---|
| Founded | 1990 | 1982 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.3M | 104.0M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | CEE | ANIX |
|---|---|---|
| Price | $17.48 | $3.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 22.0K | ★ 235.2K |
| Earning Date | 01-01-0001 | 03-10-2026 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.80 | $2.28 |
| 52 Week High | $10.32 | $5.46 |
Technical Indicators
Market Signals| Indicator | CEE | ANIX |
|---|---|---|
| Relative Strength Index (RSI) | 50.65 | 37.92 |
| Support Level | $17.03 | $3.07 |
| Resistance Level | $17.94 | $3.36 |
| Average True Range (ATR) | 0.55 | 0.17 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 42.67 | 1.92 |
Price Performance
Historical ComparisonAbout CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.